Cargando…

A Review of the Rationale for Additional Therapeutic Interventions to Attain Lower LDL-C When Statin Therapy Is Not Enough

Statins alone are not always adequate therapy to achieve low-density lipoprotein (LDL) goals in many patients. Many options are available either alone or in combination with statins that makes it possible to reach recommended goals in a safe and tolerable fashion for most patients. Ezetimibe and bil...

Descripción completa

Detalles Bibliográficos
Autor principal: Shanes, Jeffrey G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Current Science Inc. 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3252497/
https://www.ncbi.nlm.nih.gov/pubmed/22109348
http://dx.doi.org/10.1007/s11883-011-0222-z
_version_ 1782220637658415104
author Shanes, Jeffrey G.
author_facet Shanes, Jeffrey G.
author_sort Shanes, Jeffrey G.
collection PubMed
description Statins alone are not always adequate therapy to achieve low-density lipoprotein (LDL) goals in many patients. Many options are available either alone or in combination with statins that makes it possible to reach recommended goals in a safe and tolerable fashion for most patients. Ezetimibe and bile acid sequestrants reduce cholesterol transport to the liver and can be used in combination. Niacin is very effective at lowering LDL, beyond its ability to raise high-density lipoprotein and shift LDL particle size to a less atherogenic type. When statins cannot be tolerated at all, red yeast rice can be used if proper formulations of the product are obtained. Nutrients can also be added to the diet, including plant stanols and sterols, soy protein, almonds, and fiber, either individually or all together as a portfolio diet. A clear understanding of how each of these strategies works is essential for effective results.
format Online
Article
Text
id pubmed-3252497
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Current Science Inc.
record_format MEDLINE/PubMed
spelling pubmed-32524972012-01-20 A Review of the Rationale for Additional Therapeutic Interventions to Attain Lower LDL-C When Statin Therapy Is Not Enough Shanes, Jeffrey G. Curr Atheroscler Rep Statin Drugs (M Clearfield, Section Editor) Statins alone are not always adequate therapy to achieve low-density lipoprotein (LDL) goals in many patients. Many options are available either alone or in combination with statins that makes it possible to reach recommended goals in a safe and tolerable fashion for most patients. Ezetimibe and bile acid sequestrants reduce cholesterol transport to the liver and can be used in combination. Niacin is very effective at lowering LDL, beyond its ability to raise high-density lipoprotein and shift LDL particle size to a less atherogenic type. When statins cannot be tolerated at all, red yeast rice can be used if proper formulations of the product are obtained. Nutrients can also be added to the diet, including plant stanols and sterols, soy protein, almonds, and fiber, either individually or all together as a portfolio diet. A clear understanding of how each of these strategies works is essential for effective results. Current Science Inc. 2011-11-23 2012 /pmc/articles/PMC3252497/ /pubmed/22109348 http://dx.doi.org/10.1007/s11883-011-0222-z Text en © The Author(s) 2011 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Statin Drugs (M Clearfield, Section Editor)
Shanes, Jeffrey G.
A Review of the Rationale for Additional Therapeutic Interventions to Attain Lower LDL-C When Statin Therapy Is Not Enough
title A Review of the Rationale for Additional Therapeutic Interventions to Attain Lower LDL-C When Statin Therapy Is Not Enough
title_full A Review of the Rationale for Additional Therapeutic Interventions to Attain Lower LDL-C When Statin Therapy Is Not Enough
title_fullStr A Review of the Rationale for Additional Therapeutic Interventions to Attain Lower LDL-C When Statin Therapy Is Not Enough
title_full_unstemmed A Review of the Rationale for Additional Therapeutic Interventions to Attain Lower LDL-C When Statin Therapy Is Not Enough
title_short A Review of the Rationale for Additional Therapeutic Interventions to Attain Lower LDL-C When Statin Therapy Is Not Enough
title_sort review of the rationale for additional therapeutic interventions to attain lower ldl-c when statin therapy is not enough
topic Statin Drugs (M Clearfield, Section Editor)
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3252497/
https://www.ncbi.nlm.nih.gov/pubmed/22109348
http://dx.doi.org/10.1007/s11883-011-0222-z
work_keys_str_mv AT shanesjeffreyg areviewoftherationaleforadditionaltherapeuticinterventionstoattainlowerldlcwhenstatintherapyisnotenough
AT shanesjeffreyg reviewoftherationaleforadditionaltherapeuticinterventionstoattainlowerldlcwhenstatintherapyisnotenough